Segment Information (Tables)

6 Months Ended

Jun. 30, 2014

Segment Information

Schedule of consolidated financial information by segment

	Three months ended June 30,		Six months ended June 30,
(in millions)	2014	2013	2014	2013
HUMIRA	$3,288	$2,606	$5,925	$4,850
AndroGel	218	258	472	498
Synagis	74	70	428	415
Kaletra	216	278	411	497
Lupron	186	199	375	380
Synthroid	166	153	323	272
Sevoflurane	154	137	296	274
Creon	110	106	217	196
Duodopa	56	44	108	83
Dyslipidemia products	65	371	161	715
All other	393	470	773	841
Net sales	$4,926	$4,692	$9,489	$9,021